Zhang J, Li M, Wang T, Tian W, Ju J, Xu H
Front Endocrinol (Lausanne). 2025; 16:1523731.
PMID: 40060375
PMC: 11885296.
DOI: 10.3389/fendo.2025.1523731.
Nilghaz M, Sadeghi A, Koochakpoor G, Poustchi H, Khodadadi N, Narimani B
Sci Rep. 2025; 15(1):7020.
PMID: 40016311
PMC: 11868424.
DOI: 10.1038/s41598-025-88393-7.
Zhou L, Sun D, Bai H
Front Nutr. 2025; 12:1524830.
PMID: 39927279
PMC: 11804523.
DOI: 10.3389/fnut.2025.1524830.
Shanka N, Pavlov C, Mekonnen N
Front Med (Lausanne). 2025; 11:1459569.
PMID: 39911662
PMC: 11794003.
DOI: 10.3389/fmed.2024.1459569.
Zou C, Liu X, He M, Sun Y, Sang Y, Peng G
Int J Prev Med. 2025; 15:77.
PMID: 39867257
PMC: 11759225.
DOI: 10.4103/ijpvm.ijpvm_221_23.
Association of steatotic liver disease with all-cause and cardiovascular mortality among prehypertensive or hypertensive patients.
Yan S, Li Q, Cao W, Pei H, Zhen S, Wu Q
J Glob Health. 2025; 15():04003.
PMID: 39819662
PMC: 11737813.
DOI: 10.7189/jogh.15.04003.
Association between the triglyceride to high-density lipoprotein cholesterol ratio and type 2 diabetes mellitus in non-alcoholic fatty liver disease.
Bian L, Tang T, Yu Q, Tong X, Hu S, You Y
Sci Rep. 2024; 14(1):31048.
PMID: 39730877
PMC: 11680680.
DOI: 10.1038/s41598-024-82116-0.
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease.
Raverdy V, Tavaglione F, Chatelain E, Lassailly G, De Vincentis A, Vespasiani-Gentilucci U
Nat Med. 2024; 30(12):3624-3633.
PMID: 39653777
PMC: 11645276.
DOI: 10.1038/s41591-024-03283-1.
The moderating effect of cardiometabolic factors on the association between hepatic and intrapancreatic fat.
Skudder-Hill L, Sequeira-Bisson I, Ko J, Poppitt S, Petrov M
Obesity (Silver Spring). 2024; 32(12):2310-2320.
PMID: 39523209
PMC: 11589540.
DOI: 10.1002/oby.24154.
Nonalcoholic Fatty Liver Disease Risk and Proprotein Convertase Subtilisin Kexin 9 in Familial Hypercholesterolemia Under Statin Treatment.
Hamasaki M, Sakane N, Kotani K
Nutrients. 2024; 16(21).
PMID: 39519519
PMC: 11547339.
DOI: 10.3390/nu16213686.
How improvements in US FDA regulatory process and procedures led to the drug approval for first ever treatment of a common liver disease.
Harvey B
Acta Pharmacol Sin. 2024; 46(3):515-524.
PMID: 39511464
PMC: 11845757.
DOI: 10.1038/s41401-024-01396-4.
Clopidogrel ameliorates high-fat diet-induced hepatic steatosis in mice through activation of the AMPK signaling pathway and beyond.
Tai T, Shao Y, Zheng Y, Jiang L, Han H, Yin N
Front Pharmacol. 2024; 15:1496639.
PMID: 39508046
PMC: 11537861.
DOI: 10.3389/fphar.2024.1496639.
Higher Adherence to the Mediterranean Diet Is Associated with a Lower Risk of Steatotic, Alcohol-Related, and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Analysis.
Lee J, Kim S, Lee Y, Kwon Y, Lee J
Nutrients. 2024; 16(20).
PMID: 39458545
PMC: 11510508.
DOI: 10.3390/nu16203551.
Increased inter-atrial and intra-atrial conduction times in pediatric patients with non-alcoholic fatty liver disease.
El Amrousy D, Ashry H, Maher S, Elsayed Y, Elkashlan K, Abdelhai D
Eur J Pediatr. 2024; 183(12):5489-5496.
PMID: 39438332
PMC: 11527969.
DOI: 10.1007/s00431-024-05809-8.
MASLD in persons with HIV is associated with high cardiometabolic risk as evidenced by altered advanced lipoprotein profiles and targeted metabolomics.
Lin K, Vilar-Gomez E, Corey K, Connelly M, Gupta S, Lake J
Lipids Health Dis. 2024; 23(1):339.
PMID: 39420356
PMC: 11484191.
DOI: 10.1186/s12944-024-02317-4.
Possible protective effect of natural flavanone naringenin-reduced graphene oxide nanosheets on nonalcoholic fatty liver disease.
Abdelmoneim D, Eldomany E, El-Adl M, Farghali A, El-Sayed G, El-Sherbini E
Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39414698
DOI: 10.1007/s00210-024-03495-9.
Interaction between non-alcoholic fatty liver disease and obesity on the risk of developing cardiovascular diseases.
Wang X, You J, Tang J, Li X, Wang R, Li Y
Sci Rep. 2024; 14(1):24024.
PMID: 39402185
PMC: 11473819.
DOI: 10.1038/s41598-024-74841-3.
Cholecystectomy and risk of cardiovascular disease, all-cause and cause-specific mortality: a systematic review and updated meta-analysis.
Song Y, Wang H, Xu Y
PeerJ. 2024; 12:e18174.
PMID: 39364358
PMC: 11448656.
DOI: 10.7717/peerj.18174.
Carotid Intima-Media Thickness in Indian Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and a Meta-Analysis.
Kumar R, Narayan R
Cureus. 2024; 16(9):e68439.
PMID: 39360047
PMC: 11445799.
DOI: 10.7759/cureus.68439.
Long-term antibody response after the third dose of inactivated SARS-CoV-2 vaccine in MASLD patients.
Cui J, Wang L, Ghavamian A, Li X, Wang G, Wang T
BMC Gastroenterol. 2024; 24(1):329.
PMID: 39350092
PMC: 11441169.
DOI: 10.1186/s12876-024-03402-9.
